血管内成像指导冠状动脉药物洗脱支架植入:更新的网络荟萃分析
这项系统综述与更新的网络荟萃分析检索了建库至2023年8月30日的MEDLINE、Embase和Cochrane数据库,纳入22项随机对照试验共15964例患者,比较血管内成像(血管内超声或OCT)指导与单纯血管造影指导的药物洗脱支架PCI。结果显示血管内成像指导降低靶病变失败、心源性死亡、靶血管心肌梗死、靶病变血运重建、支架血栓、所有心肌梗死和全因死亡风险;OCT指导与血管内超声指导结局相似。
要点
- 血管内成像指导较血管造影指导降低靶病变失败风险(RR 0.71,95%CI 0.63-0.80)。
- 血管内成像指导降低心源性死亡、靶血管心肌梗死和靶病变血运重建风险。
- OCT指导与血管内超声指导的结局相似。
核心结论
- 与血管造影指导相比,OCT或血管内超声指导冠状动脉支架植入可提高PCI的安全性和有效性,降低死亡、心肌梗死、再次血运重建和支架血栓风险。
研究设计与样本
- 系统综述与更新的网络荟萃分析,检索MEDLINE、Embase和Cochrane数据库从建库至2023年8月30日。
- 纳入22项随机对照试验,共15964例接受药物洗脱支架PCI的患者,随机分配至血管内超声或OCT或两者或单纯血管造影指导。
- 加权平均随访24.7个月,各研究最长随访6至60个月。
- 主要终点为靶病变失败,定义为心源性死亡、靶血管心肌梗死或靶病变血运重建的复合终点。
- 研究注册于PROSPERO,注册号CRD42023455662。
主要发现
- 与血管造影指导相比,血管内成像指导降低靶病变失败风险(RR 0.71,95%CI 0.63-0.80;p<0.0001)。
- 血管内成像指导降低心源性死亡风险(RR 0.55,95%CI 0.41-0.75;p=0.0001)。
- 血管内成像指导降低靶血管心肌梗死风险(RR 0.82,95%CI 0.68-0.98;p=0.030)。
- 血管内成像指导降低靶病变血运重建风险(RR 0.72,95%CI 0.60-0.86;p=0.0002)。
- 血管内成像指导降低支架血栓风险(RR 0.52,95%CI 0.34-0.81;p=0.0036)、所有心肌梗死风险(RR 0.83,95%CI 0.71-0.99;p=0.033)和全因死亡风险(RR 0.75,95%CI 0.60-0.93;p=0.0091)。
关键数值与推荐
- OCT指导与血管内超声指导的结局相似。
临床怎么用
- 与血管造影指导相比,OCT或血管内超声指导冠状动脉支架植入可提高PCI的安全性和有效性,降低死亡、心肌梗死、再次血运重建和支架血栓风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Previous meta-analyses have shown reduced risks of composite adverse events with intravascular imaging-guided percutaneous coronary intervention (PCI) compared with angiography guidance alone. However, these studies have been insufficiently powered to show whether all-cause death or all myocardial infarction are reduced with intravascular imaging guidance, and most previous intravascular imaging studies were done with intravascular ultrasound rather than optical coherence tomography (OCT), a newer imaging modality. We aimed to assess the comparative performance of intravascular imaging-guided PCI and angiography-guided PCI with drug-eluting stents. METHODS: For this systematic review and updated meta-analysis, we searched the MEDLINE, Embase, and Cochrane databases from inception to Aug 30, 2023, for studies that randomly assigned patients undergoing PCI with drug-eluting stents either to intravascular ultrasound or OCT, or both, or to angiography alone to guide the intervention. The searches were done and study-level data were extracted independently by two investigators. The primary endpoint was target lesion failure, defined as the composite of cardiac death, target vessel-myocardial infarction (TV-MI), or target lesion revascularisation, assessed in patients randomly assigned to intravascular imaging guidance (intravascular ultrasound or OCT) versus angiography guidance. We did a standard frequentist meta-analysis to generate direct data, and a network meta-analysis to generate indirect data and overall treatment effects. Outcomes were expressed as relative risks (RRs) with 95% CIs at the longest reported follow-up duration. This study was registered with the international prospective register of systematic reviews (PROSPERO, number CRD42023455662). FINDINGS: 22 trials were identified in which 15 964 patients were randomised and followed for a weighted mean duration of 24·7 months (longest duration of follow-up in each study ranging from 6 to 60 months). Compared with angiography-guided PCI, intravascular imaging-guided PCI resulted in a decreased risk of target lesion failure (RR 0·71 [95% CI 0·63-0·80]; p<0·0001), driven by reductions in the risks of cardiac death (RR 0·55 [95% CI 0·41-0·75]; p=0·0001), TV-MI (RR 0·82 [95% CI 0·68-0·98]; p=0·030), and target lesion revascularisation (RR 0·72 [95% CI 0·60-0·86]; p=0·0002). Intravascular imaging guidance also reduced the risks of stent thrombosis (RR 0·52 [95% CI 0·34-0·81]; p=0·0036), all myocardial infarction (RR 0·83 [95% CI 0·71-0·99]; p=0·033), and all-cause death (RR 0·75 [95% CI 0·60-0·93]; p=0·0091). Outcomes were similar for OCT-guided and intravascular ultrasound-guided PCI. INTERPRETATION: Compared with angiography guidance, intravascular imaging guidance of coronary stent implantation with OCT or intravascular ultrasound enhances both the safety and effectiveness of PCI, reducing the risks of death, myocardial infarction, repeat revascularisation, and stent thrombosis. FUNDING: Abbott.
引用
- Stone GW, Christiansen EH, Ali ZA, et al. Intravascular imaging-guided coronary drug-eluting stent implantation: an updated network meta-analysis. Lancet. 2024. PMID: 38401549. doi:10.1016/S0140-6736(23)02454-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。